High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia
Year: 2024
Type: article
Abstract: ABSTRACT: Histologic transformation of Waldenström macroglobulinemia (HT-WM) carries a poor prognosis with standard treatments. Here, we report the first series of HT-WM treated with chimeric antigen receptor T cells showing a high efficacy and no unexpected toxicity.
Source: Blood
Authors: Eric Durot, Damien Roos-Weil, Adrien Chauchet, Justine Decroocq, Roberta Di Blasi, Thomas Gastinne, Hedi Bensaber, Morgane Cheminant, Caroline Jacquet, Stéphanie Guidez, François-Xavier Gros, Emmanuel Bachy, Arthur Coste, Pascale Cony-Makhoul, Steven P. Treon, Alain Delmer, Ran Reshef, Steven Le Gouill, Jorge J. Castillo, Roch Houot
Institutions: Centre Hospitalier Universitaire de Reims, Sorbonne Université, Pitié-Salpêtrière Hospital, Centre Hospitalier Universitaire de Besançon, Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Hôpital Cochin, Institut Cochin, Hôpital Saint-Louis, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire de Clermont-Ferrand, Hôpital Necker-Enfants Malades, Assistance Publique – Hôpitaux de Paris, Centre Hospitalier Régional et Universitaire de Nancy, Centre Hospitalier Universitaire de Poitiers, Centre Hospitalier Universitaire de Bordeaux, Hospices Civils de Lyon, The Lymphoma Academic Research Organisation, Hôpital Lyon Sud, Harvard University, Dana-Farber Cancer Institute, Hôpital Robert-Debré, Columbia University Irving Medical Center, Institut Curie, Centre Hospitalier Universitaire de Rennes
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4395677185